Stay updated on DSP-5336 in Relapsed AML Clinical Trial

Sign up to get notified when there's something new on the DSP-5336 in Relapsed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DSP-5336 in Relapsed AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label changed from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-18T14:27:23.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The study record for the Phase 1/2 enzomenib trial is now displayed, including its eligibility criteria, study design, outcome measures, and recruiting locations.
    Difference
    100%
    Check dated 2026-11-11T17:18:05.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-28T15:39:56.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH website updates and a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-21T20:31:27.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page, with its displayed site revision changing from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-14T20:11:38.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T20:36:58.000Z thumbnail image

Stay in the know with updates to DSP-5336 in Relapsed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DSP-5336 in Relapsed AML Clinical Trial page.